Section Arrow
TMDX.NASDAQ
- TransMedics Group
Quotes are at least 15-min delayed:2025/12/08 12:31 EST
Regular Hours
Last
 141.02
+4.51 (+3.30%)
Day High 
142.95 
Prev. Close
136.51 
1-M High
156 
Volume 
207.77K 
Bid
140.31
Ask
141.17
Day Low
136.45 
Open
137.26 
1-M Low
111.0381 
Market Cap 
4.67B 
Currency 美元 
P/E 53.54 
%Yield -- 
10-SMA 141.66 
20-SMA 130.89 
50-SMA 124.37 
52-W High 156 
52-W Low 55 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.54/2.40
Enterprise Value
5.18B
Balance Sheet
Book Value Per Share
10.39
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
23.60M
Operating Revenue Per Share
5.61
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.1831+0.0061+3.45%-- 
BSXBoston Scientific Corp92.83-4.69-4.81%52.15PE
BFLYButterfly Network3.215+0.155+5.07%-- 
ABTAbbott Laboratories122.62-2.46-1.97%15.71PE
PACBPacific Biosciences of California2.345-0.045-1.88%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.